Pro Dex IncPDEX

PRO DEX INC is a regulated investment company whose business is captured in a single phrase: it runs a fund under the Investment Company Act of 1940. That regulatory label is the closest thing the company has to a consumer brand, because the fund’s reporting and compliance obligations are what the market actually sees in filings. The latest 10-Q for the quarter ending 31 March 2026 shows $19.9 million in revenues, $3.9 million in net income attributable to the parent, and $1.20 in diluted earnings per share across 3.3 million diluted shares. Cash generation is the bright spot: net cash provided by operating activities clocked in at $7.5 million, while the company held $6.6 million in cash and equivalents and $986,000 in short-term investments at quarter-end.

What PRO DEX actually sells is regulated fund management, a service wrapped in layers of statutory disclosure rather than a flashy app or a viral product. The fund’s value proposition is stability and compliance, not technological disruption, and the filings confirm that stability: operating income was $3.1 million for the quarter, while total assets reached $75.0 million against $29.8 million in liabilities. The company’s inventory position-$22.4 million at quarter-end and down by $731,000 during the period-sits on the balance sheet like a warehouse receipt for the fund’s underlying holdings rather than a sign of aggressive inventory build.

These numbers come straight from the 10-Q dated 31 March 2026. The company’s research and development spend was a modest $827,000, and capital expenditure on property, plant, and equipment was $280,000, figures that underscore a low-capex, compliance-heavy business model rather than a high-growth tech venture. Stockholders’ equity attributable to the parent stood at $45.2 million, giving the balance sheet a sturdy look compared with the Section 30(h) filings that the board keeps approving in triplicate.

There are no analyst estimates, valuation commentary, or trading volumes baked into these filings; the market for PRO DEX shares is thinly disclosed and not covered by the evidence. What is visible is the board’s routine Section 30(h) approvals, each labelled “OMB APPROVAL,” which are regulatory permissions rather than evidence of product momentum. The latest 13D/A filing shows a beneficial owner disclosing a 5.8% stake, a disclosure that arrives just as the diluted share count sits at 3.3 million, a coincidence that highlights ownership optics rather than growth optics.

If you want a visual, imagine a fund manager filing filing trail while a warehouse full of receipts sits quietly in the background-each receipt is an audited line item, and the filing trail is the noise. The platform story likes to talk about transformation, but the balance sheet talks about cash, inventory, and compliance. The two stories do not speak to each other.